- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske studier sponset av French Innovative Leukemia Organisation
Totalt 69 resultater
-
French Innovative Leukemia OrganisationAvsluttetB-celle kronisk lymfatisk leukemi (B-CLL)Frankrike
-
French Innovative Leukemia OrganisationAvsluttet
-
French Innovative Leukemia OrganisationFullført
-
French Innovative Leukemia OrganisationFullførtLeukemi, lymfatisk, kronisk
-
French Innovative Leukemia OrganisationFullførtLeukemi, lymfatisk, akuttFrankrike
-
French Innovative Leukemia OrganisationFullført
-
French Innovative Leukemia OrganisationFullførtWaldenstrom makroglobulinemiFrankrike
-
French Innovative Leukemia OrganisationAktiv, ikke rekrutterendeAkutt myeloid leukemiFrankrike
-
French Innovative Leukemia OrganisationFullført
-
French Innovative Leukemia OrganisationFullførtB-celle kronisk lymfatisk leukemiFrankrike
-
French Innovative Leukemia OrganisationAvsluttet
-
French Innovative Leukemia OrganisationAvsluttet
-
French Innovative Leukemia OrganisationRekrutteringWaldenstroms sykdom | Prognostisk indeksFrankrike
-
French Innovative Leukemia OrganisationRekruttering
-
French Innovative Leukemia OrganisationRekrutteringUbehandlet kronisk lymfatisk leukemiFrankrike
-
French Innovative Leukemia OrganisationRekrutteringKronisk lymfoid leukemiFrankrike
-
French Innovative Leukemia OrganisationFullført
-
French Innovative Leukemia OrganisationFullførtDiffust stort B-celle lymfomFrankrike
-
French Innovative Leukemia OrganisationFullført
-
French Innovative Leukemia OrganisationFullført
-
French Innovative Leukemia OrganisationFullført
-
French Innovative Leukemia OrganisationFullført
-
French Innovative Leukemia OrganisationAmgenFullførtRichters syndromFrankrike
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationHar ikke rekruttert ennå
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationHar ikke rekruttert ennå
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationFullførtTilbakefallende AML for voksne | Ildfast AML | FLT3-TKD-mutasjon | FLT3-ITDFrankrike
-
French Innovative Leukemia OrganisationAmgenFullført
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationRekrutteringAML, voksen | Tilbakefallende AML for voksne | Ildfast AML | FLT3-TKD-mutasjon | FLT3-ITDFrankrike
-
French Innovative Leukemia OrganisationFresenius KabiFullførtAkutt myeloid leukemi (AML)Frankrike
-
French Innovative Leukemia OrganisationCelgene CorporationFullførtAkutt myeloid leukemiFrankrike
-
French Innovative Leukemia OrganisationNovartis PharmaceuticalsAktiv, ikke rekrutterende
-
French Innovative Leukemia OrganisationNovartis PharmaceuticalsAvsluttetEssensiell trombocytemiFrankrike
-
French Innovative Leukemia OrganisationJanssen, LPAktiv, ikke rekrutterendeTilbakefallende eller refraktær kronisk lymfatisk leukemiFrankrike
-
French Innovative Leukemia OrganisationNovartis PharmaceuticalsFullført
-
French Innovative Leukemia OrganisationRoche Pharma AGFullførtB-celle kronisk lymfatisk leukemi CLLFrankrike
-
University Hospital, AngersFrench Innovative Leukemia OrganisationUkjentAkutt lymfatisk leukemi hos voksneFrankrike
-
French Innovative Leukemia OrganisationHoffmann-La RocheFullført
-
French Innovative Leukemia OrganisationHoffmann-La RocheRekruttering
-
French Innovative Leukemia OrganisationUniversity Hospital, LilleRekrutteringProlymfocytisk leukemi | T-celle leukemiFrankrike
-
French Innovative Leukemia OrganisationBristol-Myers SquibbFullførtLiten lymfatisk leukemi | KLL, tilbakefall | CLL, ildfast | Bruton tyrosinkinasehemmerFrankrike
-
University Hospital, ToulouseFrench Innovative Leukemia OrganisationFullførtAkutt myeloid leukemiFrankrike
-
French Innovative Leukemia OrganisationLymphoma Study AssociationFullført
-
French Innovative Leukemia OrganisationMundipharma Pte Ltd.FullførtT-celle lymfomFrankrike
-
University Hospital, GrenobleFrench Innovative Leukemia OrganisationFullførtPerifert T-celle lymfomFrankrike
-
French Innovative Leukemia OrganisationNovartis; Schering SAFullførtGOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the ElderlyAkutt myeloid leukemiFrankrike
-
The Lymphoma Academic Research OrganisationFrench Innovative Leukemia OrganisationFullført
-
French Innovative Leukemia OrganisationAcute Leukemia French Association; French Intergroup of Myeloproliferative...RekrutteringAkutt myeloid leukemi | Myeloproliferativt syndromFrankrike
-
French Innovative Leukemia OrganisationFrench Intergroup of Myeloproliferative syndromesFullførtMyeloproliferativ neoplasma | Covid-19-infeksjonFrankrike
-
French Innovative Leukemia OrganisationGenzyme, a Sanofi Company; Acute Leukemia French AssociationAvsluttetAkutt myeloid leukemiFrankrike
-
French Innovative Leukemia OrganisationAbbVie; Janssen-Cilag Ltd.Aktiv, ikke rekrutterendeMiddels risiko for kronisk lymfatisk leukemi | Passe pasienter | Risikotilpasset og MRD-drevet strategiFrankrike